Editorial
Open access
Are there true and false classifications in noninvasive liver disease assessment for metabolic dysfunction-associated steatotic liver disease?
Sep 2026 · Hepatobiliary surgery and nutrition · Vol 15, pp. 289 - 304 · 0 citations
· 15 references
Medicine
Abstract
HW, et al. Histological severity and hepatic outcomes in patients with metabolic dysfunction-associated steatotic liver disease and discrepant FIB-4 and liver stiffness measurement. Clin Mol Hepatol 2026;32:289-304